Artosi, F. (2025) “Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series”, Dermatology Practical & Conceptual, 15(4), p. 5570. doi:10.5826/dpc.1504a5570.